相关实验视频
Updated: Sep 13, 2025

04:27
Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
5.7K
吸入和全身类固醇治疗支气管肺形:针对炎症和氧化应激
Francesca Galletta1, Alessandra Li Pomi2, Sara Manti1
1Pediatric Unit, Department of Human Pathology in Adult and Developmental Age 'Gaetano Barresi', University of Messina, 98124 Messina, Italy.
Antioxidants (Basel, Switzerland)
|July 29, 2025
概括
皮质类固醇可能有助于早产婴儿患有支气管肺功能障碍 (BPD),但全身类固醇会引起神经发育方面的担忧. 吸入类固醇是一种潜在的替代品,但需要更多关于BPD管理最佳使用的研究.
科学领域:
- 新生儿科学 新生儿科学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 支气管肺功能障碍症 (BPD) 是早产婴儿的慢性肺部疾病,以异常的肺部发育和炎症为标志.
- 皮质类固醇因其抗炎和氧化压力调节作用而被探索为BPD.
研究的目的:
- 审查目前关于吸入和全身皮质类固醇用于BPD预防和管理的证据.
- 分析皮质类固醇治疗在BPD中的疗效,安全性和长期结果.
主要方法:
- 对BPD中皮质类固醇使用现有文献的叙述性综述.
- 对研究系统性 (如德克萨米他) 和吸入性皮质类固醇的分析.
主要成果:
- 系统性皮质类固醇在减少呼吸机依赖和肺炎方面表现出有效性.
- 有关全身类固醇对神经发育的不良影响存在担忧,限制了常规使用.
- 吸入类固醇对改变BPD轨迹的有效性仍在争论中.
结论:
- 在BPD中,最佳时间,剂量和患者选择对于皮质类固醇治疗至关重要.
- 需要进一步的研究来完善剂量,并确定从皮质类固醇中受益最多的患者子组.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
314
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
314
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
397
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
397
Drugs Used in Lower Respiratory Disorders: Overview
589
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
589
Asthma: Pathogenesis and Management
597
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
597
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K

